Tag: Autoimmune treatment

In a study of 56 sarcoidosis patients, 78% reported side effects with prednisone, compared to 49% with methotrexate [1.2.4]. This article explores the critical question: **Which is better, methotrexate or prednisone?**, detailing their distinct roles in managing inflammatory and autoimmune diseases.

In the United States, over 1.5 million people have lupus and over 1.3 million live with rheumatoid arthritis [1.7.1]. For many, a key question is: **Is Plaquenil an immunosuppressant?** This drug is a cornerstone of therapy, but its classification is often misunderstood.

As a cornerstone in the treatment of many autoimmune conditions, methotrexate (MTX) is frequently prescribed for vasculitis, leveraging its potent immunomodulatory effects to reduce inflammation. This article explores **how does methotrexate work for vasculitis**, detailing its complex mechanisms that help control disease activity and induce remission.

According to long-term clinical trial data spanning up to 5 years, the medication Otezla (apremilast) has demonstrated a generally consistent and favorable safety profile. However, patients considering or currently on this medication often have questions about **what are the long-term effects of taking Otezla**, from continued side effects to impacts on vital organ systems.

Clinical trials have shown that patients with plaque psoriasis treated with Bimzelx can experience significant skin clearance (PASI 75) in as little as four weeks. This rapid response offers a clear advantage for individuals seeking quick relief from the symptoms of autoimmune diseases, helping to answer the key question, **what is the onset of action of Bimzelx?**

According to WebMD, about 30% to 40% of people with rheumatoid arthritis on a biologic stop using it, often because it stops working or causes intolerable side effects. Learning how do you know if your biologic is not working is key to getting the right treatment. This comprehensive guide details the signs of treatment failure and the steps to take next.

For decades, patients with Sjögren's have lacked targeted treatments for the underlying causes of their disease. Exciting breakthroughs are now emerging from clinical trials, which is why many are asking: **What is the new medication for Sjogren's?** Research and development have introduced several promising new candidates, including nipocalimab and ianalumab.

According to recent studies, the risk of hydroxychloroquine-induced retinopathy can be as high as 20% after 20 years of use. While a vital treatment for autoimmune conditions like lupus and rheumatoid arthritis, understanding **what is the major toxic effect of hydroxychloroquine?** is crucial for long-term patient safety.

In Japan, over 18,000 patients have received treatment for Behçet's disease, a form of vasculitis, for which Humira is an approved therapy [1.10.1]. The question remains, **does Humira work for vasculitis** in its other forms? This article explores its use.

Dexamethasone is one of the most potent synthetic glucocorticoids available, with anti-inflammatory effects estimated to be 25 to 30 times stronger than hydrocortisone. The question, "Is dexamethasone a strong drug?" is definitively answered yes, but its potency also dictates its specific uses, risks, and necessary precautions for safe administration.